logo
Target fires hundreds of Little Village warehouse employees apparently for medical loan scheme

Target fires hundreds of Little Village warehouse employees apparently for medical loan scheme

CBS News3 hours ago
Hundreds of Target workers in Chicago appear to be out of a job after a scheme to not pay back medical loans offered by the company.
An internal investigation found team members violated the company's ethics at the Little Village warehouse.
A Block Club Chicago report says the firings all stem from the company's medical loan program, which gave out loans of more than $3,00 to cover expenses.
But a loophole let some workers pay back just $50 of the loan and get the remaining balance erased.
Up to 700 employees may have been fired; the scheme cost the company $1 million.
Target told CBS News Chicago there are now measures in place to prevent this from happening again.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Student killed in stabbing at high school after fight escalates: Police
Student killed in stabbing at high school after fight escalates: Police

Yahoo

time15 minutes ago

  • Yahoo

Student killed in stabbing at high school after fight escalates: Police

A student was killed in a stabbing at a Phoenix high school on Tuesday in what school officials called a "senseless tragedy." The incident occurred at Maryvale High School, officials said. Officers responded to the school around 11 a.m. to a call for a stabbing, Phoenix police said. Phoenix Commander David Saflar said the incident "started off with a fight between two students, and escalated." MORE: Search on for suspect who stabbed ranger in state park near Denver: Police School staff notified the on-campus school safety officer, who detained one of the people involved, according to Phoenix Police Chief Matt Giordano. Two students were transported to an area hospital, including one with life-threatening injuries, police said. A male student has since died, officials said. "What happened today at Maryvale is truly a tragedy," Saflar said at a press briefing Tuesday. No additional suspects are being sought, he said. The Phoenix Police Department is investigating the incident. No further details are being released at this time, said police, who have not provided any details on the weapon used in the stabbing or the students involved. Authorities urged anyone with information, including any cellphone footage, to reach out to police. Phoenix Union High School District Superintendent Thea Andrade said the district is cooperating fully with the investigation. "Maryvale is a beautiful, resilient community and I am shocked and deeply saddened by what took place here today," Andrade said at the press briefing, calling the incident a "senseless tragedy." The school will be on a modified schedule on Wednesday to provide "extensive emotional support and counseling to our students and to our staff," Andrade said. MORE: Texas teen indicted for murder in fatal stabbing of another student at track meet Phoenix Mayor Kate Gallego thanked the first responders and police and said more information will be released as it becomes available. "Tomorrow, it will be a hard moment to drop a kid off at school, and so to the parents out there, know that we are working as hard as we can to make sure that schools are as safe as possible," Gallego said at the briefing. Arizona Superintendent of Public Instruction Tom Horne called the deadly stabbing a "terrible tragedy." "Schools must be safe places," Horne said in a statement. "This terrible incident reinforces my commitment to doing everything possible to make schools safe.'

XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

Yahoo

time15 minutes ago

  • Yahoo

XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies

CAMBRIDGE, Mass., Aug. 19, 2025 /PRNewswire/ -- XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointly develop therapeutics for immunological and inflammatory diseases. This collaboration will be based on XtalPi's intelligent and automated drug discovery platform, which integrates artificial intelligence (AI), quantum physics, and large-scale automated robotic experiments. The two companies plan to co-identify targets and discover first-in-class or best-in-class drug candidates using XtalPi's proprietary AI-driven drug discovery platform. The XtalPi platform combines the speed and generative power of AI with the accuracy of its robotic lab-in-the-loop to accelerate drug discovery and vastly expand the explorable chemical space. This integrated workflow spans deep-learning-based molecule design, quantum physics and molecular dynamics simulations for predicting drug-target interactions, automated chemical synthesis, and experimental validation of candidate compounds' key pharmaceutical properties. Leveraging its expertise in immunology and inflammation as well as its experience in small molecule drug development, Dong-A ST will actively participate throughout the entire R&D process—including candidate validation, efficacy and safety testing, and the formulation of preclinical and clinical development strategies. The company also plans to explore strategies for pipeline expansion and assess commercialization potential. Through this partnership, Dong-A ST aims to strengthen its pipeline in the immunology and inflammation space and expand its R&D scope beyond small molecule therapeutics into areas such as targeted protein degradation (TPD), biologics, antibody-drug conjugates (ADC), and gene therapies. John Wang, Senior Vice President of Drug Discovery at XtalPi, stated: "The combination of Dong-A ST's extensive expertise and XtalPi's proven AI-robotics platform is well-positioned to translate scientific innovation into competitive precision medicines. Together, we aim to rapidly discover and rigorously validate novel drug candidates across multiple modalities to unlock unique market opportunities, and deliver transformative therapies for global patients." Jae-Hong Park, Head of R&D at Dong-A ST, remarked, "This collaboration marks a pivotal step in expanding Dong-A ST's R&D capabilities," adding, "By leveraging synergies with XtalPi's AI platform, we expect to accelerate the development of next-generation treatments for immune and inflammatory diseases." Meanwhile, both Dong-A ST and XtalPi operate open innovation offices in Boston, USA. This geographic proximity will facilitate closer and more efficient collaboration throughout the drug discovery process. About Dong-A ST Dong-A ST Co., Ltd. ( was established in 1932 and is a leading Korean pharmaceutical company engaged in the development, manufacturing, and commercialization of ethical drugs, biosimilars, medical devices, and diagnostics. Its key products include Stillen (gastritis), Zydena (erectile dysfunction), Motilitone (functional dyspepsia), and Imuldosa (ustekinuma biosimilar). Leveraging strong R&D capabilities and a history of innovation, Dong-A ST is expanding its pipeline in immunology, inflammation, neurological disease, metabolic diseases, and oncology, while advancing into new modalities such as biologics, ADCs, TPD, and gene therapies. About XtalPi XtalPi Holdings Limited (XtalPi, was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries. View original content to download multimedia: SOURCE XtalPi Inc. Sign in to access your portfolio

California American Water Completes Acquisition of Bass Lake Water Company
California American Water Completes Acquisition of Bass Lake Water Company

Yahoo

time15 minutes ago

  • Yahoo

California American Water Completes Acquisition of Bass Lake Water Company

BASS LAKE, Calif., August 19, 2025--(BUSINESS WIRE)--California American Water announced today that it has completed its acquisition of the Bass Lake Water Company system. The purchase of the system, which serves approximately 1,000 customers, was previously approved by the California Public Utilities Commission (CPUC) and reflects California American Water's ongoing commitment to strengthening water infrastructure and enhancing service in communities around the state. "We're thrilled to begin providing Bass Lake customers with high-quality water service," said Kevin Tilden, President, California American Water. "We anticipate a smooth transition of services, delivering valuable experience, expertise, and a comprehensive range of customer service programs provided by California American Water to our new customers." California American Water will begin to provide water service to Bass Lake customers on August 19, 2025. Residents will receive additional information in the mail from California American Water within the next week to facilitate a smooth transition. Bass Lake residents will be able to take advantage of the company's customer service benefits, including its online account management portal, MyWater. Additional information is also available on a dedicated webpage, Bass Lake Water, on the company's website at "This agreement is a win for our community," said Steve Wetch, President of Bass Lake Water Company. "By selling the water system to California American Water we're securing the needed expertise to successfully operate our new water treatment plant and make required infrastructure improvements to provide high-quality service. The residents of Bass Lake will benefit from these improvements for decades to come." This is California American Water's eighth acquisition in the past five years, adding more than 13,000 new water and/or wastewater customers since 2020. About American Water American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Water's 6,700 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders. For more information, visit and join American Water on LinkedIn, Facebook, X and Instagram. About California American Water California American Water, a subsidiary of American Water provides safe, clean, reliable and affordable water and wastewater services to approximately 700,000 people. For more information, visit and follow California American Water on LinkedIn, Facebook, X, and Instagram. View source version on Contacts Media Contact: Jason AlviarManager, External AffairsCalifornia American WaterPhone: (916) 291-1195Email: Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store